We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




Electric Pulses Destroy Cancer Cells

By HospiMedica staff writers
Posted on 16 Jul 2007
A minimally invasive method called irreversible electroporation (IRE) causes cancer cells to die.

A team of researchers at Virginia Tech-Wake Forest University School of Biomedical Engineering and Science (SBES, Blacksberg, USA) and The University of California Berkeley (Berkeley, CA, USA) applied electroporation--a phenomenon known for decades that increases the permeability of a cell from none to a reversible opening to an irreversible opening--to the targeting of cancer cells. More...
The researchers then successfully ablated tissue using the IRE pulses in the livers of male rats. By adjusting the electrical current, the researchers were able to reliably kill the targeted cells without affecting surrounding tissue or nearby blood vessels. The process was detailed in a special issue of Technology in Cancer Research and Treatment published in August 2007.

IRE removes tumors by irreversibly opening tumor cells through a series of short intense electric pulses from small electrodes placed in or around the body, said researcher Rafael V. Davalos, Ph.D., an assistant professor of biomedical engineering at SBES. This application creates permanent openings in the pores in the cells of the undesirable tissue. The openings eventually lead to the death of the cells without the use of potentially harmful chemotherapeutic drugs.

IRE shows remarkable promise as a minimally invasive, inexpensive surgical technique to treat cancer, continued Professor Davalos. It has the advantages that it is easy to apply, is not affected by local blood flow, and can be monitored and controlled using electrical impedance tomography.

IRE was invented by Davalos, who is the 2006 recipient of the Hispanic Engineer National Achievement Award for most promising engineer or scientist, and by Boris Rubinsky, Ph.D. a bioengineering professor at the University of California (Berkeley, USA).


Related Links:
Virginia Tech-Wake Forest University School of Biomedical Engineering and Science
The University of California Berkley

Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Head Rest
Medifa 61114_3
VTE Prevention System
Flowtron ACS900
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Critical Care

view channel
Image: The researchers grew pancreatic tissue (above) so it incorporated a mesh-like electronic network (red). Cells within the tissue produce insulin (green). (Photo courtesy of Penn Medicine)

‘Cyborg’ Transplants Could Replace Pancreatic Tissue Damaged by Diabetes

Type 1 diabetes destroys insulin-producing islet cells, forcing patients to rely on lifelong insulin therapy or scarce organ transplants. Although lab-grown pancreatic tissue offers a promising alternative,... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.